2023 Q1 Form 10-K Financial Statement

#000168316823002002 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.309M $1.444M $7.529M
YoY Change -28.66% -12.22% 3.46%
Cost Of Revenue $313.0K $540.0K $3.354M
YoY Change -52.14% -6.41% 27.77%
Gross Profit $996.0K $904.0K $4.175M
YoY Change -15.66% -15.36% -10.25%
Gross Profit Margin 76.09% 62.6% 55.45%
Selling, General & Admin $3.244M $3.547M $13.99M
YoY Change -7.71% 3.02% -21.51%
% of Gross Profit 325.7% 392.37% 335.16%
Research & Development $1.796M $1.873M $6.465M
YoY Change 8.85% 27.76% 2.16%
% of Gross Profit 180.32% 207.19% 154.85%
Depreciation & Amortization $397.0K $383.0K $1.308M
YoY Change 27.24% 21.97% 67.69%
% of Gross Profit 39.86% 42.37% 31.33%
Operating Expenses $5.040M $5.420M $20.46M
YoY Change -2.42% 10.41% -15.31%
Operating Profit -$4.044M -$4.516M -$16.28M
YoY Change 1.51% 17.57% -16.51%
Interest Expense $731.0K -$678.0K $2.359M
YoY Change -1144.29% 6680.0% 3474.24%
% of Operating Profit
Other Income/Expense, Net $41.00K
YoY Change
Pretax Income -$4.734M -$5.194M -$16.23M
YoY Change 16.77% 34.87% -13.68%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.734M -$5.194M -$16.23M
YoY Change 16.77% 34.87% -13.68%
Net Earnings / Revenue -361.65% -359.7% -215.55%
Basic Earnings Per Share -$0.22 -$0.82
Diluted Earnings Per Share -$0.22 -$0.25 -$0.82
COMMON SHARES
Basic Shares Outstanding 21.25M shares 21.15M shares 19.79M shares
Diluted Shares Outstanding 21.07M shares 19.79M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $411.0K $3.015M $3.015M
YoY Change -93.24% -26.46% -26.46%
Cash & Equivalents $411.0K $3.015M $3.015M
Short-Term Investments
Other Short-Term Assets $372.0K $1.877M $1.877M
YoY Change -42.59% 427.25% 427.25%
Inventory
Prepaid Expenses
Receivables $470.0K $530.0K $530.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.253M $5.422M $5.422M
YoY Change -84.14% -1.24% -1.24%
LONG-TERM ASSETS
Property, Plant & Equipment $2.505M $2.158M $3.710M
YoY Change -25.22% 103.58% 3.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $141.0K $143.0K $143.0K
YoY Change -14.55% -13.86% -13.86%
Total Long-Term Assets $3.955M $3.853M $3.853M
YoY Change 12.52% 2.94% 2.94%
TOTAL ASSETS
Total Short-Term Assets $1.253M $5.422M $5.422M
Total Long-Term Assets $3.955M $3.853M $3.853M
Total Assets $5.208M $9.275M $9.275M
YoY Change -54.38% 0.45% 0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.511M $1.273M $1.273M
YoY Change 87.24% 77.3% 77.3%
Accrued Expenses $524.0K $446.0K $740.0K
YoY Change -72.86% -16.48% -49.63%
Deferred Revenue $166.0K $455.0K
YoY Change -18.75%
Short-Term Debt $10.74M $10.11M $10.11M
YoY Change
Long-Term Debt Due $658.0K $667.0K $667.0K
YoY Change -81.23% 3.57% 3.57%
Total Short-Term Liabilities $13.84M $13.25M $13.25M
YoY Change 110.24% 290.71% 290.71%
LONG-TERM LIABILITIES
Long-Term Debt $5.000K $10.00K $10.00K
YoY Change -99.8% -98.51% -98.51%
Other Long-Term Liabilities $199.0K $231.0K $231.0K
YoY Change -81.69% -81.52% -81.52%
Total Long-Term Liabilities $204.0K $241.0K $241.0K
YoY Change -94.23% -87.47% -87.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.84M $13.25M $13.25M
Total Long-Term Liabilities $204.0K $241.0K $241.0K
Total Liabilities $14.04M $13.49M $13.49M
YoY Change 38.82% 153.86% 153.86%
SHAREHOLDERS EQUITY
Retained Earnings -$101.1M -$96.33M
YoY Change 20.26%
Common Stock $212.0K $212.0K
YoY Change 10.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $362.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$8.832M -$4.215M -$4.215M
YoY Change
Total Liabilities & Shareholders Equity $5.208M $9.275M $9.275M
YoY Change -54.38% 0.45% 0.45%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$4.734M -$5.194M -$16.23M
YoY Change 16.77% 34.87% -13.68%
Depreciation, Depletion And Amortization $397.0K $383.0K $1.308M
YoY Change 27.24% 21.97% 67.69%
Cash From Operating Activities -$2.312M -$3.633M -$13.19M
YoY Change -33.39% -3.94% -20.34%
INVESTING ACTIVITIES
Capital Expenditures $4.000K $366.0K $307.0K
YoY Change -102.5% -2387.5% -126.72%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$301.0K -$366.0K -$1.479M
YoY Change 88.13% 2187.5% 28.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.000K 108.0K $13.58M
YoY Change -99.84% -85.5% 166.3%
NET CHANGE
Cash From Operating Activities -$2.312M -3.633M -$13.19M
Cash From Investing Activities -$301.0K -366.0K -$1.479M
Cash From Financing Activities $9.000K 108.0K $13.58M
Net Change In Cash -$2.604M -3.891M -$1.085M
YoY Change -231.58% 27.45% -91.39%
FREE CASH FLOW
Cash From Operating Activities -$2.312M -$3.633M -$13.19M
Capital Expenditures $4.000K $366.0K $307.0K
Free Cash Flow -$2.316M -$3.999M -$13.50M
YoY Change -30.05% 6.19% -12.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000736012
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 intz Restricted Stock Awards
RestrictedStockAwards
usd
CY2022 intz Restricted Stock Awards
RestrictedStockAwards
usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3015000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3015000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4100000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1456000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1260000 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39608
CY2022 dei Entity Registrant Name
EntityRegistrantName
INTRUSION INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1911917
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
101 EAST PARK BLVD
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 1200
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
PLANO
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
CY2022 dei City Area Code
CityAreaCode
(972)
CY2022 dei Local Phone Number
LocalPhoneNumber
234-6400
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
INTZ
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
69240768 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21248195 shares
CY2022 dei Auditor Firm
AuditorFirmId
726
CY2022 dei Auditor Name
AuditorName
Whitley Penn LLP
CY2022 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3015000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4100000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
530000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1034000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1877000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
356000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5422000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5490000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2865000 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2517000 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
1380000 usd
CY2021Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
0 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
78000 usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
67000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4366000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2627000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2208000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1567000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1060000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1048000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1709000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
504000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
808000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
166000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3853000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3743000 usd
CY2022Q4 us-gaap Assets
Assets
9275000 usd
CY2021Q4 us-gaap Assets
Assets
9233000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1273000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
718000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
446000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
534000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
667000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
644000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
294000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
935000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
10114000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
455000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
560000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13249000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3391000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
673000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1250000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1923000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21198000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19135000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21188000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19125000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
212000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
191000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10000 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10000 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92304000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84230000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96326000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80097000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4215000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3919000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9275000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9233000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7529000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7277000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3354000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3621000 usd
CY2022 us-gaap Gross Profit
GrossProfit
4175000 usd
CY2021 us-gaap Gross Profit
GrossProfit
3656000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6510000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10935000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6465000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6328000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7483000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5896000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-16283000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-19503000 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
2028000 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
722000 usd
CY2022 us-gaap Interest Expense
InterestExpense
2359000 usd
CY2021 us-gaap Interest Expense
InterestExpense
21000 usd
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
385000 usd
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16229000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18802000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16229000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18802000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19791000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17992000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19791000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17992000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15661000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5556000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1260000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18802000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3919000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1456000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1985000 usd
CY2022 intz Tax Withholdings Related To Stockbased Compensation Awards
TaxWithholdingsRelatedToStockbasedCompensationAwards
9000 usd
CY2022 intz Registered Direct Offering Proceeds Net Of Fees
RegisteredDirectOfferingProceedsNetOfFees
4296000 usd
CY2022 intz Issuance Of Common Stock To Terminate Operating Lease
IssuanceOfCommonStockToTerminateOperatingLease
200000 usd
CY2022 intz Nonregistered Private Placement
NonregisteredPrivatePlacement
100000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16229000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4215000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16229000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18802000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1308000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
780000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1456000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1260000 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
304000 usd
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
243000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
861000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2022 intz Noncash Interest On Notes Payable
NoncashInterestOnNotesPayable
1463000 usd
CY2021 intz Noncash Interest On Notes Payable
NoncashInterestOnNotesPayable
0 usd
CY2022 intz Gain Loss On Termination Modification Of Lease
GainLossOnTerminationModificationOfLease
385000 usd
CY2021 intz Gain Loss On Termination Modification Of Lease
GainLossOnTerminationModificationOfLease
17000 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16704000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3015000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4100000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
35000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
20000 usd
CY2022 intz Capitalized Assets And Capitalized Software Included In Accounts Payable
CapitalizedAssetsAndCapitalizedSoftwareIncludedInAccountsPayable
261000 usd
CY2021 intz Capitalized Assets And Capitalized Software Included In Accounts Payable
CapitalizedAssetsAndCapitalizedSoftwareIncludedInAccountsPayable
0 usd
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
635000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-504000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-172000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1533000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
206000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
218000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1040000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-193000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-105000 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
383000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13190000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16557000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
307000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1063000 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1172000 usd
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
-0 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
85000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1479000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1148000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
710000 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1500000 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
645000 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
699000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1985000 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
5556000 usd
CY2022 intz Proceeds From Registered Direct Offering Net Of Fees
ProceedsFromRegisteredDirectOfferingNetOfFees
4296000 usd
CY2021 intz Proceeds From Registered Direct Offering Net Of Fees
ProceedsFromRegisteredDirectOfferingNetOfFees
0 usd
CY2022 intz Proceeds From Nonregistered Private Placement
ProceedsFromNonregisteredPrivatePlacement
100000 usd
CY2021 intz Proceeds From Nonregistered Private Placement
ProceedsFromNonregisteredPrivatePlacement
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
67000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
244000 usd
CY2022 intz Tax Withholdings Related To Stockbased Compensation Awards
TaxWithholdingsRelatedToStockbasedCompensationAwards
9000 usd
CY2021 intz Tax Withholdings Related To Stockbased Compensation Awards
TaxWithholdingsRelatedToStockbasedCompensationAwards
-0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13584000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5101000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1085000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-12604000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4100000 usd
CY2022 intz Common Stock Issued For Lease Termination
CommonStockIssuedForLeaseTermination
200000 usd
CY2021 intz Common Stock Issued For Lease Termination
CommonStockIssuedForLeaseTermination
0 usd
CY2022 intz Assets Acquired Under Right Of Use Rou Operating Lease
AssetsAcquiredUnderRightOfUseRouOperatingLease
0 usd
CY2021 intz Assets Acquired Under Right Of Use Rou Operating Lease
AssetsAcquiredUnderRightOfUseRouOperatingLease
489000 usd
CY2022 intz Assets Acquired Under Rou Finance Lease
AssetsAcquiredUnderRouFinanceLease
5000 usd
CY2021 intz Assets Acquired Under Rou Finance Lease
AssetsAcquiredUnderRouFinanceLease
1995000 usd
CY2022Q4 intz Working Capital
WorkingCapital
7800000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_z9Ny20M05Mi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86D_zesh2cQuMHBd">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but not limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, depreciation, income taxes and stock-based compensation. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
500000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1000000 usd
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1200000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zLQSxAsUx1Hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_861_zcgdEZsBkt0h">Risk Concentration</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consists primarily of cash and cash equivalents, investments, and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, the Company places its investments in U.S. government obligations, corporate securities, and money market funds. Substantially all the Company’s cash, cash equivalents and investments are maintained with one major U.S. financial institution. The Company does not believe that it is subject to any unusual financial risk with the Company’s banking arrangements. The Company has not experienced any significant losses on its cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company sells its products to customers primarily in the U.S. In the future, the Company may sell the Company’s products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. The Company performs ongoing credit evaluations of its customers’ financial condition and generally require no collateral. The Company maintains reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s operations are concentrated in one area - security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--SevenGovernmentCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUx2LdrwtTbi" title="Percentage of revenues">65.8</span>% of total revenues attributable to seven government customers and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--FiveGovernmentCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVT3RudRwlOf" title="Percentage of revenues">71.4</span>% of total revenues attributable to seven government customers for the years ended December 31, 2022, and 2021, respectively. Three individual government customers and two individual commercial customers during the year ended December 31, 2022, individually accounted for over <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeGovernmentCustomersAndOneCommercialCustomerMember_ze4B5N2RZCk8">10</span>% of total revenues and during the year ended December 31, 2021, three government customers and one commercial, individually accounted for over <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeGovernmentCustomersMember_zyXniElk6rJf">10</span>% of total revenues. The Company’s similar product and service offerings are not viewed as individual segments, as the Company’s management analyzes the business as a whole and expenses are not allocated to each product offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
600000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
500000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
177000 usd
CY2022 intz Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1877000 usd
CY2021 intz Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1953000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
500000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1000000.0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2022 intz Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
-1982000 usd
CY2021 intz Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
-1570000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
455000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
500000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1300000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
673000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231000 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1317973 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
901388 shares
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
107000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
105000 usd
CY2022Q4 intz Prepaid Licenses
PrepaidLicenses
98000 usd
CY2021Q4 intz Prepaid Licenses
PrepaidLicenses
80000 usd
CY2022Q4 intz Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
1363000 usd
CY2021Q4 intz Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
0 usd
CY2022Q4 intz Prepaid Other
PrepaidOther
309000 usd
CY2021Q4 intz Prepaid Other
PrepaidOther
171000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1877000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
356000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
644000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
294000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
935000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
189000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
254000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
195000 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
211000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
36000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
22000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
446000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
534000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1048000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1709000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
504000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
808000 usd
CY2022Q4 intz Lease Assets
LeaseAssets
1552000 usd
CY2021Q4 intz Lease Assets
LeaseAssets
2517000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
667000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1250000 usd
CY2022Q4 intz Lease Liabilities
LeaseLiabilities
1202000 usd
CY2021Q4 intz Lease Liabilities
LeaseLiabilities
3502000 usd
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M28D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M8D
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0337 pure
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0335 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0342 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0470 pure
CY2022 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3200000 usd
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3200000 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
665000 usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
306000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
304000 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
341000 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
35000 usd
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
20000 usd
CY2022 intz Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
1004000 usd
CY2021 intz Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
667000 usd
CY2022 intz Operating Cash Flows For Operating Leases
OperatingCashFlowsForOperatingLeases
-1085000 usd
CY2021 intz Operating Cash Flows For Operating Leases
OperatingCashFlowsForOperatingLeases
33000 usd
CY2022 intz Operating Cash Flows For Finance Leases
OperatingCashFlowsForFinanceLeases
665000 usd
CY2021 intz Operating Cash Flows For Finance Leases
OperatingCashFlowsForFinanceLeases
306000 usd
CY2022 intz Financing Cash Flows For Finance Leases
FinancingCashFlowsForFinanceLeases
-645000 usd
CY2021 intz Financing Cash Flows For Finance Leases
FinancingCashFlowsForFinanceLeases
-699000 usd
CY2022Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Two
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo
987000 usd
CY2022Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Three
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree
131000 usd
CY2022Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Four
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour
118000 usd
CY2022 intz Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
-99000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.67
CY2021 intz Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
-257000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.97
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
156000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.16
CY2022Q4 intz Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
1236000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
500000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
900000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
1500000 usd
CY2022Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
3300000 usd
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
3095000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
149000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
5.54
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
132000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
2.66
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
97000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
6.41
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
26000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
3.85
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
158000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
2.88
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
617000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.47
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1035000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.87
CY2022 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
334000 shares
CY2022 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
3.63
CY2021 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
606000 shares
CY2021 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
12.99
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
634000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.81
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
28000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.47
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
133000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.82
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
668000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
617000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.47
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
281000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.13
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
317000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.56
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
688000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
281000 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y8M23D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.22
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.13
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
372000 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
372000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.32
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.09
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0217 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0070 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2954 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6672 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y9M3D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M14D
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15994000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22497000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
56000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
56000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
73000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
94000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
349000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
52000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
830000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
544000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17156000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23055000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17156000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23055000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3409000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3948000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
107000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
331000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
89000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-206000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5899000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2458000 usd
CY2022 intz Expiring Federal Net Operating Losses
ExpiringFederalNetOperatingLosses
9745000 usd
CY2021 intz Expiring Federal Net Operating Losses
ExpiringFederalNetOperatingLosses
0 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-419000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
2027000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
76100000 usd
CY2022 intz Employee Retention Credit
EmployeeRetentionCredit
2000000 usd
CY2022Q4 intz Erc Receivable
ERCReceivable
1400000 usd

Files In Submission

Name View Source Status
0001683168-23-002002-index-headers.html Edgar Link pending
0001683168-23-002002-index.html Edgar Link pending
0001683168-23-002002.txt Edgar Link pending
0001683168-23-002002-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
intrusion_ex1018.htm Edgar Link pending
intrusion_ex1019.htm Edgar Link pending
intrusion_ex2100.htm Edgar Link pending
intrusion_ex2301.htm Edgar Link pending
intrusion_ex3101.htm Edgar Link pending
intrusion_ex3102.htm Edgar Link pending
intrusion_ex3201.htm Edgar Link pending
intrusion_ex3202.htm Edgar Link pending
intrusion_i10k-123122.htm Edgar Link pending
intz-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
intz-20221231_def.xml Edgar Link unprocessable
intz-20221231_lab.xml Edgar Link unprocessable
intrusion_i10k-123122_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
intz-20221231_cal.xml Edgar Link unprocessable
intz-20221231_pre.xml Edgar Link unprocessable